Trials / Completed
CompletedNCT06496880
A Study to Evaluate the Efficacy of OxyjunTM on Cardiac Pumping Capacity as Well as Work Productivity in Individuals With Metabolic Risk.
A Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy of OxyjunTM on Cardiac Pumping Capacity as Well as Work Productivity in Individuals With Metabolic Risk
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Vedic Lifesciences Pvt. Ltd. · Industry
- Sex
- All
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
A Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate Efficacy of OxyjunTM on Cardiac Pumping Capacity as well as Work Productivity in Individuals with Metabolic Risk.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oxyjun TM | One capsule daily to be taken after breakfast for 56 days |
| DIETARY_SUPPLEMENT | Placebo | One capsule daily to be taken after breakfast for 56 days |
Timeline
- Start date
- 2024-09-10
- Primary completion
- 2025-02-17
- Completion
- 2025-02-17
- First posted
- 2024-07-11
- Last updated
- 2025-06-12
Locations
7 sites across 1 country: India
Source: ClinicalTrials.gov record NCT06496880. Inclusion in this directory is not an endorsement.